23 July 2019, Change in Substantial Holding
Change in Substantial Holding
Ethics Approval to Use Monepantel Tablet in Dogs with Cancer
190715_Dog Phase II
Top 20 Shareholders, 5 July 2019
190705_Top20Shareholders
PharmAust Featured in BioWorld
190703_BWT06112019
Epichem’s Completes New Laboratory Financing on Time
190702_Epichem Loan_Repayment
GMP Manufacture for Phase 2 Canine Trials
190604_GMP Manufacture
Top 20 Shareholders, 31 May 2019
Top_Holders_Report (22)
25 kg of GMP Monepantel from Elanco
190508_GMP_25kg
Appendix 4C and Quarterly Update
444r10lc14lvz2
30 April, Top 20 Shareholders
Top_Holders_Report (2)